Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001432274 | SCV001635039 | likely benign | Bloom syndrome | 2024-04-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003307655 | SCV003999958 | likely benign | Hereditary cancer-predisposing syndrome | 2023-06-12 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003479236 | SCV004223155 | likely benign | not specified | 2023-11-25 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001432274 | SCV002089902 | likely benign | Bloom syndrome | 2021-08-02 | no assertion criteria provided | clinical testing |